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Purpose/Objective: High dose-rate (HDR) skin brachytherapy positions 
sources in close proximity to the patient surface. The most popular 
technique consists on a simple planar implant using paralle lcatheters 
following the skin surface using moulds. Most treatment planning 
systems (TPS) use the TG-43 dose calculation formalism and therefore 
assume sources positioned within an infinite water medium without 
accounting for the backscatter defect due to the surrounding air. The 
purpose of this work is to evaluate theTG-43 limitations and clinical 
implications when using a typical superficial mould with an HDR 
source in contact with the skin surface, with and without backscatter 
bolus. The evaluation was performed for the two currently available 
HDR radionuclides 192Ir and 60Co. 
Materials and Methods: The following configurations have been 
considered: 
1) With the mould embedded within an infinite water medium (i.e., 
TG-43 conditions).  
2) With the mould positioned over the skin in a semi-infinite water 
medium, 
3) A single source instead of a mould, to mimic the worst clinical 
situation, with the same configuration as in 1), but with 5, 10, or 20 
mm of bolus and also without any bolus, i.e., with the source located 
directly over the skin surface. 
In cases 1) and 2), a realistic treatment plan where the source 
occupies several different positions were considered. In case 3), the 
source is positioned at a single location. Dose distributions have been 
obtained using the Monte Carlo (MC) code GEANT4 (version9.4). 
Results: For 192Ir, differences in the dose rate distributions between 
cases 1) and 2) ranged from 1.5% to 3% at the skin surface, see Fig. 1. 
At a typical prescription depth of 5 mm, differences were 2.5% to 3%. 
For case 3) without bolus, dose rate differences were < 2%for < 5 mm 
depths. When 10 or 20 mm boluses were added, the differences were 
negligible. For 60Co with no bolus, the differences up to 15% were in 
the vicinity of the surface. For either radionuclide, the effect of the 
high dose gradient (factors of 19 and 15 for 192Ir and 60Co,respectively) 
between the surface and prescription depth was the predominant 
effect. 
 Fig. 1.Dose ratio between cases 1) and 2) at the skin surface depth of 
zero. 
 
Conclusions: Dosimetric differences in susceptibility to backscatter 
conditions for skin brachytherapy were negligible for 192Ir and 60Co. 
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Purpose/Objective: Evaluation of back scattered radiation (BSR) from 
the secondary collimators into linac beam monitor chamber has been 
of limited use in treatment planning (TP) dose calculations so far as 
effect of this radiation component has been incorporated into the 
collimator scatter factor. In Monte Carlo (MC) calculations this 
radiation component can be explicitly modeled and incorporated into 
absolute dose calculations as previously shown by our group (Popescu 
et al., 2005). Modern TP dose calculations increasingly involve fast MC 
algorithms. Simplified source models and particle phase spaces are 
commonly used in place of full radiation transport through the linac 
head to reduce calculation time. Explicit modeling of BSR becomes 
impractical in such situations and experimental measurements as well 
as MC pre-calculated values can be used instead. The purpose of this 
study is to evaluate experimentally and through MC modeling the back 
scatter factors (BSFs) defined as a ratio of the charge collected in 
beam monitor chamber for a given field to that of a reference 
(10x10cm2) field. 
Materials and Methods: Experimental measurements were performed 
for 6MV and 18MV beams from Varian 21EX, and for 6MV, 10MV, 10MV 
FFF, 15MV beams from Varian TrueBeam linacs. Experimental setup 
was used similar to that by Kubo (Kubo, 1989). However instead of 
narrow slits a very small (<2 mm diameter) stereotactic collimator and 
a PTW pinpoint ionization chamber with effective volume of 0.0125 
cm3, positioned at extended SDD, were used providing less than 3mm 
field of view to the source.  
MC calculations using BEAMnrc and DOSXYZnrc codes were done for 
6MV and 18 MV beam models of Varian 21EX linac. Various fields sizes 
from 1x1cm2 to 40x40cm2 were used and BSFs were calculated as 
described previously (Popescu et al.,2005). MC modeling of BSF from 
TrueBeam was not possible due to lack of manufacturer's 
specifications required for MC modeling of this machine. 
Results: For 21EX beams and field sizes modeled in this study, 
measured BSFs agreed with MC calculated values within 1%. The BSF 
values for 21EX decreased from 1.02 for the 1x1cm2 field size to 0.99 
for 40x40cm2 fields. For all measured TrueBeam beam energies the 
BSF variation across field sizes was within ±1%. 
Conclusions: The BSFs factors derived in this study for 21EX linac 
allow accommodating them in fast MC calculations and remove up to 
2% of potential error that would have been present in absolute dose 
calculations had these factors been ignored. For Varian TrueBeam 
linacs effect of potential error due to ignoring BSF would be within 
1%. 
Kubo H 1989 Telescopic measurements of backscattered radiation 
from secondary collimator jaws to abeam monitor chamber using a 
pair of slits Medical Physics 16 295-8 
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Purpose/Objective: Several articles have been published comparing 
the results of Monte Carlo (MC) simulations with treatment planning 
system calculations, both generally and on a site-specific basis e.g. 
for prostate, head and neck and lung treatments. However, 
publications for oesophageal radiotherapy are rare, despite the fact 
that the treatment volume lies in a region of heterogeneous anatomy 
involving a number of organs at risk (e.g. spinal cord, heart, lung). 
The aim of this work is to develop an efficient framework for 
performing MC simulations of clinical oesophageal treatments, so that 
the results of a statistically significant number of clinical cases may 
be compared in order to evaluate the differences between planning 
algorithms as robustly as possible. 
Materials and Methods: Radical oesophageal radiotherapy plans are 
now routinely produced in our centre according to a protocol 
originally developed for the UK national SCOPE trial. Plans were 
performed using the Pencil Beam Enhanced (PBE) and Collapsed Cone 
Enhanced (CCE) algorithms within Nucletron Oncentra MasterPlan 
(OMP v3.3 Service Pack 1). The DICOM CT, Structure Set, Plan and 
Dose files are exported from OMP for clinical plans. Python scripts 
were used to anonymise the data, remove any private DICOM tags, and 
alter Region Of Interest (ROIs) to follow a specific naming convention. 
The anonymised DICOM files were uploaded to our RTGrid calculation 
platform, a system that creates MC input files from DICOM files,and 
allows MC simulations to be performed on distributed computing 
resources at Cardiff University, with the results from different 
computers being automatically combined by the RTGrid system. The 
RTGrid platform has recently been adapted to handle CT scans 
involving iodine-based contrast agents and the Enhanced Dynamic 
Wedge (EDW) for Varian Linear Accelerators (linacs). After simulation, 
the 3D dose matrices produced by RTGrid were converted from energy 
deposited per photon to Gray, following the method of Liu to account 
for backscatter to the monitor chamber of the linac. The 3D dose 
matrices were then converted to DICOM-RT DOSE files, following the 
method of Teke. The MC dose distributions can either be imported 
back into OMP or, using scripts written in Matlab, in to CERR, for 
calculation of Dose Volume Histograms (DVHs) and other plan metrics.  
Results: Initial results from the study to date indicate that the dose to 
95% of the Planning Target Volume (PTV) vary by up to 5%, with 
similar levels of difference in Organ at Risk (OAR) doses.  
Conclusions: A system has been developed to perform MC simulations 
of Oesophageal treatment plans with minimal user interaction. Initial 
investigations indicate that DVH parameters used in the reporting of 
Oesophageal treatment plans varies by up to 5% when comparing MC 
simulated dose distributions to those calculated from Treatment 
Planning algorithms.  
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Purpose/Objective: The majority of our breast cancer patients are 
treated with fixed-angle IMRT, although VMAT is also available. Fixed-
angle plans fulfill the clinical objectives more closely, specially in the 
low dose levels. In recen tyears, more precise dose calculation 
algorithms became available for clinical practice. Our goal is to 
investigate for a group of breast cancer patients whether the use of a 
more precise dose calculation algorithm will affect the clinical choice 
of IMRT plans in our institution. 
Materials and Methods: Five left-sided breast cancer patients were 
selected from a group of patients already treated with fixed-angle 
IMRT in our institute. Left sided tumors were chosen in order to have 
more insight on the dose to the heart. The clinical plans of the five 
patients were generated using the ECLIPSE treatment planning system 
(version 10). Dose calculation was performed using the AAA 
convolution-based algorithm. Subsequently, the clinical plans were 
replanned using VMAT. First, the same clinical-and optimisation 
objectives were used as in the plan delivered to the patient. 
Secondly, the VMAT plans were optimized individually in order to 
produce the best possible plan. 
Finally, dose calculation was performed for all plans using ACUROSXB 
(a new deterministic-based algorithm), also available in ECLIPSE. The 
same calculation grid (0.25 cm) was applied. 
Results: Percentage differences between both VMAT and fixed-
angleIMRT are larger as compared with the dose calculation 
algorithms (see table 1.)This is largely due to the fact that the 
planning objectives used for the VMATplans were originally from the 
fixed-angle IMRT plan. In table 1 is also shown that once an 
individualized optimisation is performed for the VMAT plans, 
differences became much less pronounced. However, results obtained 
for each technique show that differences of 1-3% can be found at the 
lower dose regions (V5 Gy), especially in the lung region. Because 
doses to the heart are clinically evaluated in our institute at V10 Gy 
instead of the V5 Gy, the differences between all the plans for this 
organ seem to be less significant. 
 
 
Conclusions: Differences between the dose calculation algorithms 
indicate that the use of ACUROSXB may affect the clinical choice of 
the IMRT plan.  
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Purpose/Objective: Dose calculation algorithms might not model 
radiation dose distribution accurately in heterogeneous tissues (HT) 
such as lung and head and neck region. Latest techniques such as 
IMRT, IMAT and SRT produce sharp dose gradient by this means 
provide better dose coverage in target while reducing organs at risk 
(OARs) doses. Therefore accurate modeling is crucial to ensure 
sufficient target dose and OARs doses within tolerance limits in HT. 
This experimental and dosimetric study compared the dose 
distributions of Pencil Beam Convolution (PBC) and Anisotropic 
Analytical Algorithm (AAA) photon dose calculation algorithms in HT. 
Furthermore, IMRT plans calculated by both AAA and PBC were 
verified.  
Materials and Methods: 10 patients with non-small cell lung cancer, 
planned using IMRT were included. Primarily, all plans were 
calculated using Pencil Beam Convolution (PBC) algorithm and graded 
as reference plans. Than same plans were re-calculated using 
Anisotropic Analytical Algorithm (AAA). To ensure equal target dose 
coverage for both algorithms (PBC and AAA), dose normalization was 
made to the isodose, which is 95% of the target volume receiving 100% 
of the dose. OARs doses and maximum doses in the target between 
PBC and AAA plans were compared. Furthermore, all plans were 
delivered to homogeneous and heterogeneous phantoms and 
verification measurements made using a pinpoint ionization chamber. 
For each algorithm, calculated and actual doses were compared.  
Results: Max doses in the targets were higher for AAA than PBC plans 
(p=0.005); the differences were between 3.1-7.1%. Calculated OARs 
doses by PBC and AAA were significantly different for lung V5, V20 and 
Dmean (p values were 0.005, 0.005 and 0.013 respectively), for 
esophagus V55 and Dmean (p values were 0.005 for both criteria), and 
for heart V60 doses (p=0.043). Nevertheless, there was no significant 
difference for heart V20 (p=0.678) and spinal cord Dmax(p=0.114). 
Though, the differences for all OARs doses were less than 3%. 
Calculated and actual dose differences for homogeneous and 
heterogeneous phantoms were not significant for AAA plans (p=0.139 
andp=0.074), although were significant for PBC plans (p=0.007 and 
p=0.012). Mean difference was 1.6% in AAA and 2.4% in PBC plans for 
homogenous phantom whereas 2.6% in AAA and 6.1% in PBC plans for 
heterogeneous phantom.  
